Details
Stereochemistry | ACHIRAL |
Molecular Formula | C5H6N2 |
Molecular Weight | 94.1145 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=CC=NC=C1
InChI
InChIKey=NUKYPUAOHBNCPY-UHFFFAOYSA-N
InChI=1S/C5H6N2/c6-5-1-3-7-4-2-5/h1-4H,(H2,6,7)
Molecular Formula | C5H6N2 |
Molecular Weight | 94.1145 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 16:58:16 UTC 2023
by
admin
on
Sat Dec 16 16:58:16 UTC 2023
|
Record UNII |
BH3B64OKL9
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Brand Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C93038
Created by
admin on Sat Dec 16 16:58:19 UTC 2023 , Edited by admin on Sat Dec 16 16:58:19 UTC 2023
|
||
|
FDA ORPHAN DRUG |
18186
Created by
admin on Sat Dec 16 16:58:19 UTC 2023 , Edited by admin on Sat Dec 16 16:58:19 UTC 2023
|
||
|
FDA ORPHAN DRUG |
214205
Created by
admin on Sat Dec 16 16:58:19 UTC 2023 , Edited by admin on Sat Dec 16 16:58:19 UTC 2023
|
||
|
FDA ORPHAN DRUG |
104497
Created by
admin on Sat Dec 16 16:58:19 UTC 2023 , Edited by admin on Sat Dec 16 16:58:19 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
FAMPYRA (AUTHORIZED: MULTIPLE SCLEROSIS)
Created by
admin on Sat Dec 16 16:58:19 UTC 2023 , Edited by admin on Sat Dec 16 16:58:19 UTC 2023
|
||
|
EU-Orphan Drug |
EU/3/07/458
Created by
admin on Sat Dec 16 16:58:19 UTC 2023 , Edited by admin on Sat Dec 16 16:58:19 UTC 2023
|
||
|
NDF-RT |
N0000192795
Created by
admin on Sat Dec 16 16:58:19 UTC 2023 , Edited by admin on Sat Dec 16 16:58:19 UTC 2023
|
||
|
FDA ORPHAN DRUG |
713019
Created by
admin on Sat Dec 16 16:58:19 UTC 2023 , Edited by admin on Sat Dec 16 16:58:19 UTC 2023
|
||
|
LIVERTOX |
NBK548455
Created by
admin on Sat Dec 16 16:58:19 UTC 2023 , Edited by admin on Sat Dec 16 16:58:19 UTC 2023
|
||
|
WHO-ATC |
N07XX07
Created by
admin on Sat Dec 16 16:58:19 UTC 2023 , Edited by admin on Sat Dec 16 16:58:19 UTC 2023
|
||
|
WHO-VATC |
QN07XX07
Created by
admin on Sat Dec 16 16:58:19 UTC 2023 , Edited by admin on Sat Dec 16 16:58:19 UTC 2023
|
||
|
EPA PESTICIDE CODE |
69201
Created by
admin on Sat Dec 16 16:58:19 UTC 2023 , Edited by admin on Sat Dec 16 16:58:19 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1162454
Created by
admin on Sat Dec 16 16:58:19 UTC 2023 , Edited by admin on Sat Dec 16 16:58:19 UTC 2023
|
PRIMARY | |||
|
7283
Created by
admin on Sat Dec 16 16:58:19 UTC 2023 , Edited by admin on Sat Dec 16 16:58:19 UTC 2023
|
PRIMARY | |||
|
1727
Created by
admin on Sat Dec 16 16:58:19 UTC 2023 , Edited by admin on Sat Dec 16 16:58:19 UTC 2023
|
PRIMARY | |||
|
BH3B64OKL9
Created by
admin on Sat Dec 16 16:58:19 UTC 2023 , Edited by admin on Sat Dec 16 16:58:19 UTC 2023
|
PRIMARY | |||
|
m4072
Created by
admin on Sat Dec 16 16:58:19 UTC 2023 , Edited by admin on Sat Dec 16 16:58:19 UTC 2023
|
PRIMARY | Merck Index | ||
|
6037
Created by
admin on Sat Dec 16 16:58:19 UTC 2023 , Edited by admin on Sat Dec 16 16:58:19 UTC 2023
|
PRIMARY | |||
|
4-aminopyridine
Created by
admin on Sat Dec 16 16:58:19 UTC 2023 , Edited by admin on Sat Dec 16 16:58:19 UTC 2023
|
PRIMARY | |||
|
2416
Created by
admin on Sat Dec 16 16:58:19 UTC 2023 , Edited by admin on Sat Dec 16 16:58:19 UTC 2023
|
PRIMARY | |||
|
100000081574
Created by
admin on Sat Dec 16 16:58:19 UTC 2023 , Edited by admin on Sat Dec 16 16:58:19 UTC 2023
|
PRIMARY | |||
|
4163
Created by
admin on Sat Dec 16 16:58:19 UTC 2023 , Edited by admin on Sat Dec 16 16:58:19 UTC 2023
|
PRIMARY | |||
|
C76777
Created by
admin on Sat Dec 16 16:58:19 UTC 2023 , Edited by admin on Sat Dec 16 16:58:19 UTC 2023
|
PRIMARY | |||
|
FF-74
Created by
admin on Sat Dec 16 16:58:19 UTC 2023 , Edited by admin on Sat Dec 16 16:58:19 UTC 2023
|
PRIMARY | |||
|
DTXSID0023870
Created by
admin on Sat Dec 16 16:58:19 UTC 2023 , Edited by admin on Sat Dec 16 16:58:19 UTC 2023
|
PRIMARY | |||
|
15041
Created by
admin on Sat Dec 16 16:58:19 UTC 2023 , Edited by admin on Sat Dec 16 16:58:19 UTC 2023
|
PRIMARY | |||
|
Dalfampridine
Created by
admin on Sat Dec 16 16:58:19 UTC 2023 , Edited by admin on Sat Dec 16 16:58:19 UTC 2023
|
PRIMARY | |||
|
504-24-5
Created by
admin on Sat Dec 16 16:58:19 UTC 2023 , Edited by admin on Sat Dec 16 16:58:19 UTC 2023
|
PRIMARY | |||
|
207-987-9
Created by
admin on Sat Dec 16 16:58:19 UTC 2023 , Edited by admin on Sat Dec 16 16:58:19 UTC 2023
|
PRIMARY | |||
|
D015761
Created by
admin on Sat Dec 16 16:58:19 UTC 2023 , Edited by admin on Sat Dec 16 16:58:19 UTC 2023
|
PRIMARY | |||
|
BH3B64OKL9
Created by
admin on Sat Dec 16 16:58:19 UTC 2023 , Edited by admin on Sat Dec 16 16:58:19 UTC 2023
|
PRIMARY | |||
|
SUB07505MIG
Created by
admin on Sat Dec 16 16:58:19 UTC 2023 , Edited by admin on Sat Dec 16 16:58:19 UTC 2023
|
PRIMARY | |||
|
34385
Created by
admin on Sat Dec 16 16:58:19 UTC 2023 , Edited by admin on Sat Dec 16 16:58:19 UTC 2023
|
PRIMARY | |||
|
DB06637
Created by
admin on Sat Dec 16 16:58:19 UTC 2023 , Edited by admin on Sat Dec 16 16:58:19 UTC 2023
|
PRIMARY | |||
|
4-AMINOPYRIDINE
Created by
admin on Sat Dec 16 16:58:19 UTC 2023 , Edited by admin on Sat Dec 16 16:58:19 UTC 2023
|
PRIMARY | |||
|
CHEMBL284348
Created by
admin on Sat Dec 16 16:58:19 UTC 2023 , Edited by admin on Sat Dec 16 16:58:19 UTC 2023
|
PRIMARY | |||
|
897018
Created by
admin on Sat Dec 16 16:58:19 UTC 2023 , Edited by admin on Sat Dec 16 16:58:19 UTC 2023
|
PRIMARY | RxNorm |
Related Record | Type | Details | ||
---|---|---|---|---|
|
BINDER->LIGAND |
BINDING
|
||
|
TARGET -> AGONIST | |||
|
TARGET -> AGONIST | |||
|
TARGET -> AGONIST | |||
|
TARGET -> AGONIST | |||
|
TARGET -> AGONIST | |||
|
TARGET -> AGONIST | |||
|
TARGET -> AGONIST | |||
|
TARGET -> AGONIST |
|
||
|
TARGET -> AGONIST | |||
|
TARGET -> AGONIST | |||
|
SALT/SOLVATE -> PARENT |
|
||
|
EXCRETED UNCHANGED |
URINE
|
||
|
TARGET -> AGONIST | |||
|
METABOLIC ENZYME -> SUBSTRATE |
MAJOR
|
||
|
TARGET -> AGONIST |
|
||
|
TARGET -> AGONIST | |||
|
TARGET -> AGONIST | |||
|
TARGET -> AGONIST |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE INACTIVE -> PARENT |
MAJOR
|
||
|
METABOLITE INACTIVE -> PARENT |
MAJOR
URINE
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Tmax | PHARMACOKINETIC |
|
|
|||
Volume of Distribution | PHARMACOKINETIC |
|
|
|||
Biological Half-life | PHARMACOKINETIC |
|
|
|||